A1 Refereed original research article in a scientific journal

Circulating metabolites in progression to islet autoimmunity and type 1 diabetes




AuthorsLamichhane S., Kemppainen E., Trošt K., Siljander H., Hyöty H., Ilonen J., Toppari J., Veijola R., Hyötyläinen T., Knip M., Orešič M., Lamichhane S.

PublisherSpringer Verlag

Publication year2019

JournalDiabetologia

Journal name in sourceDiabetologia

Volume62

First page 2287

Last page2297

DOIhttps://doi.org/10.1007/s00125-019-04980-0

Web address https://link.springer.com/article/10.1007/s00125-019-04980-0

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/42162535


Abstract

Aims/hypothesis: Metabolic dysregulation may precede the onset of type 1 diabetes. However, these metabolic disturbances and their specific role in disease initiation remain poorly understood. In this study, we examined whether children who progress to type 1 diabetes have a circulatory polar metabolite profile distinct from that of children who later progress to islet autoimmunity but not type 1 diabetes and a matched control group.

Methods: We analysed polar metabolites from 415 longitudinal plasma samples in a prospective cohort of children in three study groups: those who progressed to type 1 diabetes; those who seroconverted to one islet autoantibody but not to type 1 diabetes; and an antibody-negative control group. Metabolites were measured using two-dimensional GC high-speed time of flight MS.

Results: In early infancy, progression to type 1 diabetes was associated with downregulated amino acids, sugar derivatives and fatty acids, including catabolites of microbial origin, compared with the control group. Methionine remained persistently upregulated in those progressing to type 1 diabetes compared with the control group and those who seroconverted to one islet autoantibody. The appearance of islet autoantibodies was associated with decreased glutamic and aspartic acids.

Conclusions/interpretation: Our findings suggest that children who progress to type 1 diabetes have a unique metabolic profile, which is, however, altered with the appearance of islet autoantibodies. Our findings may assist with early prediction of the disease.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 14:24